News
FDA UpdatesLaw and AdvocacyTechnology TrendsViewpointsAll News
Media
In-Depth InsightsPharmacist ViewScript-EdExpert InterviewsPharmacy PerspectivesPodcasts
Conferences
Conference CoverageConference Listing
Resources
Disease Awareness White Board VideoAmerican Pharmacists MonthSponsored ResourcesCME/CEPartners
More
Publications
Drug Topics JournalTotal Pharmacy JournalSubmission of ArticlesSupplements And Featured Publications
Events
Virtual EventsTotal Pharmacy Solutions Summit
Business
Business StrategiesPatient ServicesPharmacy InventoryLaw and RegulationsTechnology and DataAll Business News
Practice Type
Independent PharmacyChain PharmacySpecialty PharmacyHealth System PharmacyPharmacy Technicians
Total Pharmacy

Subscribe

  • News
  • Media
  • Conferences
  • Resources
  • Publications
  • Events
  • Business
  • Practice Type
  • Subscribe
  • Total Pharmacy
  • Allergy
  • Autoimmune Diseases
  • Biosimilars
  • COVID-19
  • Cannabidiol (CBD)
  • Cardiology
  • Compounding
  • Continuous Glucose Monitoring
  • Dermatology
  • Diabetes
  • Digestive Health
  • Endocrinology
  • Eye Health
  • Generics
  • HIV
  • Headache and Migraine
  • Immunization
  • Infectious Disease
  • Influenza
  • Insulin Management
  • Medical Devices
  • Mental and Behavioral Health
  • Neurology
  • OTC
  • Obesity Management
  • Oncology
  • Pain Management
    • Nonopioid Pain Management
  • Pediatrics
  • Pneumococcal
  • Public Health
  • Rare Diseases
  • Respiratory
  • Rheumatology
  • Shingles
  • Specialty Pharmacy
  • Substance Use Disorder
  • Technology and Data
  • Veterinary Pharmacy
  • Women's Health
Spotlight -
Total Pharmacy|
NCPA Annual Convention|
FDA Updates
Advertisement

Paul Silverman

Advertisement

Articles by Paul Silverman

How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025

ByBrian Nowosielski,Dae Lee, PharmD, Esq, CPBS ,Lucas Morgan, Esq,Paul Silverman
October 24th 2025

Before delinking, pharmacy benefit managers were able to tie their fees to significantly high-priced medications, in turn receiving large percentages of compensation rather than flat, fixed fees.

Advertisement

Latest Updated Articles

  • How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
    How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025

    Published: October 24th 2025 | Updated:



Advertisement
Advertisement

Trending on Drug Topics

1

Eloralintide Reduces Weight By 9.5% to 20.1% for Patients With Obesity

2

SGLT2is Significantly Benefit Kidney, Hospitalization, and Mortality Outcomes

3

Pharmacists Guide Pneumonia Treatment, Safety, and Vaccination

4

Infectious Disease Pharmacist Breaks Down Pneumonia Types, Treatment Options

5

Pneumococcal Vaccine Rates for Black Adults Significantly Higher Than White Adults

  • About
  • Advertise
  • Editorial
  • Editorial Board
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • AdvanCE
  • Total Pharmacy
Drug Topics
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us